SCHEMBL18027768

SCHEMBL18027768

CC(C)=CCOC(=O)/C=C/c1cc(CO)c(OCC=C(C)C)c(CO)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.55
ALOX5 P09917 4/20 0.43
AKR1C3 P42330 2/20 0.41
AKR1B10 O60218 1/20 0.41
MMP2 P08253 1/20 0.41
AKR1B1 P15121 1/20 0.41
PAK1 Q13153 1/20 0.41
PTGES O14684 5/20 0.41
MAOB P27338 3/20 0.40
MEN1 O00255 1/20 0.40
NR1I2 O75469 1/20 0.40
LMNA P02545 1/20 0.40
PGR P06401 1/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
CNR1 P21554 1/20 0.40
TBXA2R P21731 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18027752 0.84 TTR (0.62) TTRALOX5AKR1C3MMP2PTGES
SCHEMBL16692680 0.82 ALOX5 (0.57) TTRALOX5PTGESMAPTHPGD
SCHEMBL18010182 0.82 ALOX5 (0.57) TTRALOX5PTGESMAPTHPGD
SCHEMBL18027757 0.81 TTR (0.62) TTRALOX5MMP2PTGESMAOB
SCHEMBL18010085 0.75 TTR (0.67) TTRALOX5PTGESMAOB
SCHEMBL16692741 0.75 TTR (0.67) TTRALOX5PTGESMAOB
SCHEMBL16692689 0.72 PTGES (0.70) TTRALOX5PTGESMAOB
SCHEMBL18010096 0.72 PTGES (0.70) TTRALOX5PTGESMAOB
SCHEMBL16692678 0.72 PTGES (0.77) TTRALOX5PTGESMAOBAPP
SCHEMBL18010087 0.72 PTGES (0.77) TTRALOX5PTGESMAOBAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682931-B2 Aryloyl(oxy or amino)pentafluorosulfanylbenzene compound, pharmaceutically acceptable salt thereof, and prodrugs thereof UBE INDUSTRIES, LTD. (JP) 2017-06-20 US disclosed
US-20160244407-A1 ARYLOYL(OXY OR AMINO)PENTAFLUOROSULFANYLBENZENE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PRODRUGS THEREOF UBE INDUSTRIES, LTD. (JP) 2016-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160244407-A1 ARYLOYL(OXY OR AMINO)PENTAFLUOROSULFANYLBENZENE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PRODRUGS THEREOF SLCO1B1, SLCO2B1, SLCO1B3 TTR 316/4885ALOX5 876/4885AKR1C3 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.